Novo Integrated Sciences EBITDA 2012-2024 | NVOS
Novo Integrated Sciences ebitda from 2012 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Novo Integrated Sciences Annual EBITDA
(Millions of US $) |
| 2024 |
$-1 |
| 2023 |
$-1 |
| 2022 |
$-16 |
| 2021 |
$-3 |
| 2020 |
$-3 |
| 2019 |
$-1 |
| 2018 |
$-1 |
| 2017 |
$0 |
| 2016 |
$0 |
| 2016 |
$0 |
| 2015 |
$2 |
| 2014 |
$0 |
| 2013 |
$0 |
| 2012 |
$-1 |
| 2012 |
$-1 |
| 2011 |
$-2 |
| 2011 |
$-2 |
Novo Integrated Sciences Quarterly EBITDA
(Millions of US $) |
| 2024-08-31 |
$-1 |
| 2024-05-31 |
$1 |
| 2024-02-29 |
$0 |
| 2023-11-30 |
$-2 |
| 2023-08-31 |
$-2 |
| 2023-05-31 |
$-1 |
| 2023-02-28 |
$2 |
| 2022-11-30 |
$0 |
| 2022-08-31 |
$-17 |
| 2022-05-31 |
$2 |
| 2022-02-28 |
$0 |
| 2021-11-30 |
$-1 |
| 2021-08-31 |
$-1 |
| 2021-05-31 |
$0 |
| 2021-02-28 |
$-1 |
| 2020-11-30 |
$0 |
| 2020-08-31 |
$-3 |
| 2020-05-31 |
$0 |
| 2020-02-29 |
$0 |
| 2019-11-30 |
$0 |
| 2019-08-31 |
$0 |
| 2019-05-31 |
$0 |
| 2019-02-28 |
$0 |
| 2018-11-30 |
$0 |
| 2018-08-31 |
$0 |
| 2018-05-31 |
$0 |
| 2018-02-28 |
$-1 |
| 2017-11-30 |
$0 |
| 2017-08-31 |
$-2 |
| 2017-05-31 |
$0 |
| 2017-03-31 |
$0 |
| 2017-02-28 |
$0 |
| 2016-12-31 |
|
| 2016-11-30 |
$0 |
| 2016-09-30 |
$0 |
| 2016-06-30 |
$0 |
| 2016-05-31 |
$0 |
| 2016-03-31 |
$0 |
| 2015-12-31 |
|
| 2015-09-30 |
$2 |
| 2015-06-30 |
$0 |
| 2015-03-31 |
$0 |
| 2014-12-31 |
|
| 2014-09-30 |
$0 |
| 2014-06-30 |
$0 |
| 2014-03-31 |
$0 |
| 2013-12-31 |
|
| 2013-09-30 |
$0 |
| 2013-06-30 |
$0 |
| 2013-03-31 |
$0 |
| 2012-12-31 |
$0 |
| 2012-09-30 |
$0 |
| 2012-08-31 |
|
| 2012-06-30 |
$0 |
| 2012-03-31 |
$0 |
| 2012-02-29 |
$0 |
| 2011-12-31 |
|
| 2011-11-30 |
$0 |
| 2011-09-30 |
$0 |
| 2011-08-31 |
$0 |
| 2011-06-30 |
$0 |
| 2011-05-31 |
$-1 |
| 2011-03-31 |
$-1 |
| 2011-02-28 |
$-1 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.000B |
$0.013B |
|
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
|
